Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Acetate for Alcohol Withdrawal in Hospitalized Patients
NCT07810946Phase 2Not yet recruiting
- Sponsor
- University of Colorado Denver
- Start
- Nov 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 2 trial of sodium acetate ringer's injection in alcohol withdrawal syndrome (AWS), sponsored by University of Colorado Denver. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
sodium acetate ringer's injection
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT07810946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07810946.